BUB1B is also a cellular target of synuclein-gamma (SNCG, also known as breast cancer specific gene 1), with which it may interact to inactivate the mitotic checkpoint, and contribute to resistance of beast cancer cells to microtubule inhibitors. Here, SNCG is linked to cancer.